RLY-4008

RLY-4008 is a novel potent and highly selective FGFR2 inhibitor designed to overcome the emergence of on-target FGFR2 resistance mutations and dose-limiting toxicities associated with current pan-FGFR inhibitors. RLY-4008 is > 200-fold selective over FGFR1, and > 80- and > 5000-fold selective over FGFR3 and FGFR4, respectively.


Cat. No.: EX-A6478	Purity: >98%

	Chemical structure of RLY-4008

For research only, Do not use for Human!

Size	Unit Price (US$)	Stock
50mg	400	In-stock
100mg	600	In-stock
250mg	950	In-stock
500mg	1350	In-stock
1g	1900	In-stock
5g	4900	In-stock

Send PO to E-mail:order@excenen.com; or Fax:+86 020 81619670

Discount Request


Synonyms	Lirafugratinib
CAS No.	2549174-42-5
Purity	>98%
Formula	C28H24FN7O2
Mol Weight	509.5343
Appearance	solid powder
Shelf Life	>2 years if stored properly
Storage	Powder -20℃ 2 years; In solvent -20℃ 1 month;
Shipping	Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Reference:	[1]. [1] Lescarbeau, Andre, et al. Preparation of substituted pyrrolopyrimidines as FGFR inhibitors and methods of making and using the same. WO2022109577.
Data Sheet	Data sheet of RLY-4008
CoA	CoA of RLY-4008
SDS	SDS of RLY-4008


		Search